_version_ 1783592269047136256
author Rial, Manuel Jorge
Valverde, Marcela
del Pozo, Victoria
González-Barcala, Francisco Javier
Martínez-Rivera, Carlos
Muñoz, Xavier
Olaguibel, José María
Plaza, Vicente
Curto, Elena
Quirce, Santiago
Barranco, Pilar
Domínguez-Ortega, Javier
Mullol, Joaquin
Picado, César
Valero, Antonio
Bobolea, Irina
Arismendi, Ebymar
Ribó, Paula
Sastre, Joaquín
author_facet Rial, Manuel Jorge
Valverde, Marcela
del Pozo, Victoria
González-Barcala, Francisco Javier
Martínez-Rivera, Carlos
Muñoz, Xavier
Olaguibel, José María
Plaza, Vicente
Curto, Elena
Quirce, Santiago
Barranco, Pilar
Domínguez-Ortega, Javier
Mullol, Joaquin
Picado, César
Valero, Antonio
Bobolea, Irina
Arismendi, Ebymar
Ribó, Paula
Sastre, Joaquín
author_sort Rial, Manuel Jorge
collection PubMed
description
format Online
Article
Text
id pubmed-7546677
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-75466772020-10-13 Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak Rial, Manuel Jorge Valverde, Marcela del Pozo, Victoria González-Barcala, Francisco Javier Martínez-Rivera, Carlos Muñoz, Xavier Olaguibel, José María Plaza, Vicente Curto, Elena Quirce, Santiago Barranco, Pilar Domínguez-Ortega, Javier Mullol, Joaquin Picado, César Valero, Antonio Bobolea, Irina Arismendi, Ebymar Ribó, Paula Sastre, Joaquín J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2021-01 2020-10-09 /pmc/articles/PMC7546677/ /pubmed/33045398 http://dx.doi.org/10.1016/j.jaip.2020.09.050 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Communications
Rial, Manuel Jorge
Valverde, Marcela
del Pozo, Victoria
González-Barcala, Francisco Javier
Martínez-Rivera, Carlos
Muñoz, Xavier
Olaguibel, José María
Plaza, Vicente
Curto, Elena
Quirce, Santiago
Barranco, Pilar
Domínguez-Ortega, Javier
Mullol, Joaquin
Picado, César
Valero, Antonio
Bobolea, Irina
Arismendi, Ebymar
Ribó, Paula
Sastre, Joaquín
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
title Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
title_full Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
title_fullStr Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
title_full_unstemmed Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
title_short Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
title_sort clinical characteristics in 545 patients with severe asthma on biological treatment during the covid-19 outbreak
topic Clinical Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546677/
https://www.ncbi.nlm.nih.gov/pubmed/33045398
http://dx.doi.org/10.1016/j.jaip.2020.09.050
work_keys_str_mv AT rialmanueljorge clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT valverdemarcela clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT delpozovictoria clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT gonzalezbarcalafranciscojavier clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT martinezriveracarlos clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT munozxavier clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT olaguibeljosemaria clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT plazavicente clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT curtoelena clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT quircesantiago clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT barrancopilar clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT dominguezortegajavier clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT mulloljoaquin clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT picadocesar clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT valeroantonio clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT boboleairina clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT arismendiebymar clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT ribopaula clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak
AT sastrejoaquin clinicalcharacteristicsin545patientswithsevereasthmaonbiologicaltreatmentduringthecovid19outbreak